These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

458 related articles for article (PubMed ID: 26514292)

  • 1. Enzyme-triggered, cell penetrating peptide-mediated delivery of anti-tumor agents.
    He H; Sun L; Ye J; Liu E; Chen S; Liang Q; Shin MC; Yang VC
    J Control Release; 2016 Oct; 240():67-76. PubMed ID: 26514292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-penetrating peptides: strategies for anticancer treatment.
    Raucher D; Ryu JS
    Trends Mol Med; 2015 Sep; 21(9):560-70. PubMed ID: 26186888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
    Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
    Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15 years of ATTEMPTS: a macromolecular drug delivery system based on the CPP-mediated intracellular drug delivery and antibody targeting.
    Ye J; Shin MC; Liang Q; He H; Yang VC
    J Control Release; 2015 May; 205():58-69. PubMed ID: 25483423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Current Role of Cell-Penetrating Peptides in Cancer Therapy.
    Feni L; Neundorf I
    Adv Exp Med Biol; 2017; 1030():279-295. PubMed ID: 29081059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CPP-Assisted Intracellular Drug Delivery, What Is Next?
    Ye J; Liu E; Yu Z; Pei X; Chen S; Zhang P; Shin MC; Gong J; He H; Yang VC
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The application of enzyme-sensitive activatable cell-penetrating peptides to targeted delivery system].
    He F; Cao L; Zhang XJ; Xiang B; Cao DY; Qi XR
    Yao Xue Xue Bao; 2015 Feb; 50(2):141-7. PubMed ID: 25975019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeting delivery of herb-based drugs with cell-penetrating/tumor-targeting peptide-modified nanocarriers.
    Kebebe D; Liu Y; Wu Y; Vilakhamxay M; Liu Z; Li J
    Int J Nanomedicine; 2018; 13():1425-1442. PubMed ID: 29563797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved Protein Toxin Delivery Based on ATTEMPTS Systems.
    Chen Y; Zhang M; Min KA; Wang H; Shin MC; Li F; Yang VC; Huang Y
    Curr Drug Targets; 2018 Feb; 19(4):380-392. PubMed ID: 28260497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug.
    Xia H; Gu G; Hu Q; Liu Z; Jiang M; Kang T; Miao D; Song Q; Yao L; Tu Y; Chen H; Gao X; Chen J
    Bioconjug Chem; 2013 Mar; 24(3):419-30. PubMed ID: 23350619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kiss and Run: Promoting Effective and Targeted Cellular Uptake of a Drug Delivery Vehicle Composed of an Integrin-Targeting Diketopiperazine Peptidomimetic and a Cell-Penetrating Peptide.
    Feni L; Parente S; Robert C; Gazzola S; Arosio D; Piarulli U; Neundorf I
    Bioconjug Chem; 2019 Jul; 30(7):2011-2022. PubMed ID: 31243977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances of anti-cancer therapies including the use of cell-penetrating peptides.
    Klimpel A; Lützenburg T; Neundorf I
    Curr Opin Pharmacol; 2019 Aug; 47():8-13. PubMed ID: 30771730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thermosensitive magnetic liposomes with doxorubicin cell-penetrating peptides conjugate for enhanced and targeted cancer therapy.
    Lin W; Xie X; Yang Y; Fu X; Liu H; Yang Y; Deng J
    Drug Deliv; 2016 Nov; 23(9):3436-3443. PubMed ID: 27193383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-penetrating peptide-doxorubicin conjugate loaded NGR-modified nanobubbles for ultrasound triggered drug delivery.
    Lin W; Xie X; Deng J; Liu H; Chen Y; Fu X; Liu H; Yang Y
    J Drug Target; 2016; 24(2):134-46. PubMed ID: 26176270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smart Cell-Penetrating Peptide-Based Techniques for Intracellular Delivery of Therapeutic Macromolecules.
    He Y; Li F; Huang Y
    Adv Protein Chem Struct Biol; 2018; 112():183-220. PubMed ID: 29680237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
    Reissmann S
    J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier.
    Yang Y; Yang Y; Xie X; Cai X; Mei X
    J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
    Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
    Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptides in protein mimicry and cancer therapeutics.
    Zorko M; Jones S; Langel Ü
    Adv Drug Deliv Rev; 2022 Jan; 180():114044. PubMed ID: 34774552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.